Comment on "Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma" by Lu et al.-The Authors' Reply.
作者信息
Lu Di, Hu Zhihang, Chen Hao, Xu Xiao
机构信息
Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital of Hangzhou Medical College, Hangzhou, China.
NHC Key Laboratory of Combined Multi-Organ Transplantation, Hangzhou, China.
出版信息
J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13762. doi: 10.1002/jcsm.13762.
Abstract
摘要
相似文献
1
Comment on "Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma" by Lu et al.-The Authors' Reply.对Lu等人所著《肌肉脂肪变性和肌肉减少对男性肝细胞癌患者肝移植结局的影响》的评论——作者回复
J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13762. doi: 10.1002/jcsm.13762.
2
Comment on 'Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma' by Lu et al.对Lu等人所著的《肌脂肪变性和肌肉减少对男性肝细胞癌患者肝移植结局的影响》的评论
J Cachexia Sarcopenia Muscle. 2024 Dec;15(6):2877-2878. doi: 10.1002/jcsm.13620. Epub 2024 Oct 20.
3
Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.肌脂肪变性和肌肉流失影响男性肝细胞癌患者的肝移植结局。
J Cachexia Sarcopenia Muscle. 2024 Oct;15(5):2071-2083. doi: 10.1002/jcsm.13554. Epub 2024 Aug 27.
4
Different cutoff values of the skeletal muscle mass and myosteatosis result in different clinical impact on overall survival in oncology. A subanalysis of a clinical trial.骨骼肌质量和肌脂肪变性的不同临界值对肿瘤学中的总生存具有不同的临床影响。一项临床试验的亚组分析。
J Cancer Res Clin Oncol. 2025 Apr 16;151(4):141. doi: 10.1007/s00432-025-06190-1.
5
Myosteatosis, the More Significant Predictor of Outcome: An Analysis of the Impact of Myosteatosis, Sarcopenia, and Sarcopenic Obesity on Liver Transplant Outcomes in Johannesburg, South Africa.肌肉脂肪变性是预后的更重要预测指标：对约翰内斯堡（南非）肝移植结局中肌肉脂肪变性、肌肉减少症和肌肉减少性肥胖的影响分析。
Exp Clin Transplant. 2021 Sep;19(9):948-955. doi: 10.6002/ect.2021.0083. Epub 2021 Aug 9.
6
Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors.进行性肌肉减少症和肌内脂肪增多症可预测接受免疫检查点抑制剂治疗的晚期 HCC 患者的预后。
Front Immunol. 2024 Apr 16;15:1396927. doi: 10.3389/fimmu.2024.1396927. eCollection 2024.
7
Myosteatosis Is Associated With Frailty and Poor Physical Function in Patients Undergoing Liver Transplant Evaluation: A Cohort Study.肌少脂性肥胖与接受肝移植评估患者的虚弱及身体功能差相关：一项队列研究。
Clin Transplant. 2024 Dec;38(12):e70034. doi: 10.1111/ctr.70034.
8
Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients.评估磁共振成像衍生的脂肪分数作为肝移植受者肌内脂肪增多的敏感可靠预测指标。
HPB (Oxford). 2020 Jan;22(1):102-108. doi: 10.1016/j.hpb.2019.06.006. Epub 2019 Aug 9.
9
Impact of CT-relevant skeletal muscle parameters on post-liver transplantation survival in patients with hepatocellular carcinoma.CT 相关骨骼肌参数对肝癌患者肝移植术后生存的影响。
Hepatol Int. 2024 Oct;18(5):1516-1527. doi: 10.1007/s12072-024-10708-z. Epub 2024 Jul 14.
10
Reply to Riva et al. Comment on "Gaspari et al. Blood Purification in Hepatic Dysfunction after Liver Transplant or Extensive Hepatectomy: Far from the Best-Case Scenarios. 2024, , 2853".回复里瓦等人。对“加斯帕里等人。肝移植或广泛肝切除术后肝功能不全的血液净化：远非最佳情况。2024年，，2853”的评论
J Clin Med. 2025 Jan 27;14(3):822. doi: 10.3390/jcm14030822.
本文引用的文献
1
Comment on 'Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma' by Lu et al.对Lu等人所著的《肌脂肪变性和肌肉减少对男性肝细胞癌患者肝移植结局的影响》的评论
J Cachexia Sarcopenia Muscle. 2024 Dec;15(6):2877-2878. doi: 10.1002/jcsm.13620. Epub 2024 Oct 20.
2
Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.肌脂肪变性和肌肉流失影响男性肝细胞癌患者的肝移植结局。
J Cachexia Sarcopenia Muscle. 2024 Oct;15(5):2071-2083. doi: 10.1002/jcsm.13554. Epub 2024 Aug 27.
3
The adverse impact of perioperative body composition abnormalities on outcomes after split liver transplantation: a multicenter retrospective cohort study.围手术期体成分异常对劈离式肝移植术后结局的不良影响：一项多中心回顾性队列研究。
Int J Surg. 2024 Jun 1;110(6):3543-3553. doi: 10.1097/JS9.0000000000001303.
4
Prevalence of and Impact on the Outcome of Myosteatosis in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.肝细胞癌患者肌脂肪变性的患病率及其对预后的影响：一项系统评价和荟萃分析
Cancers (Basel). 2024 Feb 27;16(5):952. doi: 10.3390/cancers16050952.
5
Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis.肌内脂肪变性在肝硬化患者中的流行情况及其对预后的影响：系统评价和荟萃分析。
Hepatol Int. 2024 Apr;18(2):688-699. doi: 10.1007/s12072-023-10632-8. Epub 2024 Feb 8.
6
Association of myosteatosis with treatment response and survival in patients with hepatocellular carcinoma undergoing chemoembolization: a retrospective cohort study.肌内脂肪浸润与接受化疗栓塞治疗的肝细胞癌患者治疗反应和生存的关系：一项回顾性队列研究。
Sci Rep. 2023 Mar 9;13(1):3978. doi: 10.1038/s41598-023-31184-9.
7
Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization.肌脂肪变性与接受经动脉栓塞治疗的肝癌患者的并发症或生存率无关。
J Clin Med. 2022 Dec 29;12(1):262. doi: 10.3390/jcm12010262.
8
Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.肌肉改变与肝硬化患者的轻微和显性肝性脑病相关。
Hepatology. 2019 Nov;70(5):1704-1713. doi: 10.1002/hep.30692. Epub 2019 Jun 28.
9
Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma.术前内脏脂肪过多和肌肉量少预示着肝细胞癌肝切除术后预后不良。
Liver Cancer. 2019 Mar;8(2):92-109. doi: 10.1159/000488779. Epub 2018 Jun 5.
10
Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.肌肉减少性脂肪浸润和肌肉减少症与肝硬化患者肝性脑病相关。
Hepatol Int. 2018 Jul;12(4):377-386. doi: 10.1007/s12072-018-9875-9. Epub 2018 Jun 7.
Zotero 插件